Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
ASKA Pharmaceutical Holdings Co., Ltd. ( (JP:4886) ) has provided an announcement.
ASKA Pharmaceutical Holdings Co., Ltd. reported a 2.1% year-on-year increase in net sales to 64.1 billion yen for FY2024, driven by robust performance in its pharmaceuticals and animal health businesses. Despite rising R&D expenses impacting operating profit, the company forecasts a significant 16.9% increase in net sales and a 27.5% rise in operating profit for FY2025, indicating strong future growth prospects.
More about ASKA Pharmaceutical Holdings Co., Ltd.
ASKA Pharmaceutical Holdings Co., Ltd. operates in the pharmaceutical industry, focusing on pharmaceuticals and animal health products. The company is known for its strong sales performance in these sectors, achieving record-high sales figures.
Average Trading Volume: 47,952
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen61.9B
Learn more about 4886 stock on TipRanks’ Stock Analysis page.